From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Supply@Me Capital - Interim numbers dire, minimal revenues, chunky loss and company remains technically insolvent

By Tom Winnifrith | Monday 30 September 2024


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


The fraud Supply@ME Capital (SYME) served up its interims at 14.45 PM, primarily, I suspect, because it had to wait until The Avantgarde Group Spa (TAG) had extended its loan note from ending on 30 June 2025 to 31 December 2025, to maintain the dubious proposition that Supply has the possibility of continuing to trade and isn’t hopelessly insolvent because it has a working capital facility that extends beyond 12 months of the signing of the accounts. Let’s ignore the fact that the provider The Avantgarde Group is itself financially insolvent on its filed accounts for the year ended 31 December 2021 and hasn’t paid a single cash call under latest facility.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

Time left: 05:12:51